Table 7.
Author and publication year | Study description | Route of exposure | Exposure measurement | Outcome(s) evaluated | Outcomes(s) observed | Overall confidence level for outcome | Applicability for dose–response |
---|---|---|---|---|---|---|---|
Animal studies (inhalation) | |||||||
NTP (2000) | Male and female rats (Fischer 344); 2-y (105-wk) exposure | Inhalation (whole body) | 0, 52, 157, | Histopathology of eyes | No effects observed | High. This study was well designed to evaluate this outcome. Evidence was presented clearly and transparently. | Suitable. Multidose study with quantitative data. |
NTP (1992b) | Male and female mice (B6C3F1); 2-y (103-wk) exposure | Inhalation (whole body) | 0, 52, | Examination of eyes by slit-lamp biomicroscopy and indirect ophthalmoscopic procedures | No effects observed | High (females). This study was well designed to evaluate this outcome. Evidence was presented clearly and transparently. Low (males). The high mortality rate in control males has the potential to interfere with the interpretation of results. |
Suitable. Multidose study with quantitative data. |
Animal studies (oral) | |||||||
Battelle (1980b) | Male and female rats (Fischer 344); 90-d exposure | Oral gavage | 0, 25, 50, 100, 200, | Histopathological evaluation of eyes | No effects observed | High. This study was well designed to evaluate this outcome. Evidence was presented clearly and transparently. | Suitable. Multidose studies with quantitative data. |
Battelle (1980a) | Male and female mice (B6C3F1); 90-d exposure | Oral gavage | 0, 12.5, 25, 50, 100, | Histopathological evaluation of eyes | No effects observed | High. This study was well designed to evaluate this outcome. Evidence was presented clearly and transparently. | Suitable. Multidose studies with quantitative data. |
Holmén et al. (1999) | Female rats (Brown Norway); 10-wk exposure | Oral gavage | 0, 100, 500, 1,000, (dosed twice per week) |
Evaluation of cataractous changes using lens photography | Cataractous changes correlated with naphthalene dose | Medium. Some concerns were raised over the small sample size of the control and some reporting limitations (method of dosing not reported, chemical purity not reported), but overall appears to be a well-conducted study. | Suitable. Multidose studies with quantitative data. |
Shopp et al. (1984) | Male and female mice (CD-1); 14- or 90-d exposure | Oral gavage |
14-d exposure: 0, 27, 53, 90-d exposure: 0, 5.3, 53, |
Examination of eyes (methods not reported) | No effects observed | Medium. This study was well-designed to evaluate these outcomes, but confidence was decreased because only qualitative results are provided. | Not suitable. Quantitative results not reported. |
Animal studies (dermal) | |||||||
Bushy Run (1986) | Male and female rats (Sprague-Dawley CD); 90-d exposure | Dermal | 0, 100, 300, | Examination with indirect ophthalmoscope prior to dosing and prior to final sacrifice | No effects observed | High. This study was well designed to evaluate this outcome. Evidence was presented clearly and transparently. | Suitable. Multidose study with quantitative data. |